⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Lambda Therapeutic Research and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Lambda Therapeutic Research
↗Ahmedabad, India
Lambda Therapeutic Research is a leading global Contract Research Organization (CRO) providing a full spectrum of drug development services. The company supports the pharmaceutical, biotechnology, and generic industries with services ranging from early-phase (Phase I, First-in-Human, BA/BE) to late-phase (Phase II-IV) clinical trials, as well as pharmacovigilance, data management, and medical writing.
Headquartered in Ahmedabad, India, the company has expanded its global footprint through strategic acquisitions, including the R&D facilities of Biovail CRO in Canada (2010) and Novum Pharmaceutical Research Services in the U.S. (2019). Lambda operates facilities across India, Canada, Poland, the UK, and the USA, employing over 1,500 professionals.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Founded:1999
Ownership:private
Status:operating
PIPELINE
Modalities:Small molecule, Biologics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Novum Pharmaceutical Research Services
Key Partnerships:Global Big Pharma, innovator, biopharmaceutical and generic industry clients
COMPETITION
Position:Leader
Competitors:IQVIA, Labcorp, Parexel, PPD
LEADERSHIP
Key Executives:
Bindi Chudgar - Managing Director
LINKS
Website:lambda-cro.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Lambda Therapeutic Research. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.